Loading...
Extracellular vesicles as antigen carriers for novel vaccination avenues.
Mehanny, Mina Lehr, Claus-Michael
Mehanny, Mina
Lehr, Claus-Michael
Citations
Altmetric:
Advisors
Editors
Other Contributors
Issue Date
2021-03-26
Submitted date
Files
Loading...
accepted manuscript
Adobe PDF, 5.09 MB
Other Titles
Abstract
Antigen delivery has always been a challenge in scientific practice of vaccine formulation. Yet, mammalian extracellular vesicles (EVs) or bacterial membrane vesicles (MVs) provide an innovative avenue for safe and effective delivery of antigenic material. They include intrinsically loaded antigens from EV-secreting cells or extrinsically loaded antigens onto pre-formed vesicles. Interestingly, many studies shed light on potential novel anti-cancer vaccination immunotherapy for therapeutic applications from mammalian cell host-derived EVs, as well as conventional vaccination for prophylactic applications using bacterial cell-derived MVs against infectious diseases. Here, we discuss the rationale, status quo and potential for both vaccine applications using EVs.
Citation
Adv Drug Deliv Rev. 2021 Mar 26;173:164-180. doi: 10.1016/j.addr.2021.03.016. Epub ahead of print.
Publisher
Journal
PubMed ID
PubMed Central ID
Additional Links
Embedded video
Type
Review
Language
en
Description
Series/Report no.
ISSN
EISSN
1872-8294
ISBN
ISMN
Gov't Doc #
Sponsors
License
Attribution-NonCommercial-NoDerivatives 4.0 International